Introduction
Osteoarthritis (OA) is a complex and multifactorial disease in which the knee is a frequently affected joint. The knee consists of three joints, the tibiofemoral (TF), patellofemoral (PF) and proximal tibiofibular joint, in which OA can occur in isolation or in combination. To date, most OA research effort has focused on the TF joint. This is surprising, since PF OA appears more prevalent and is a significant source of pain and associated disability [1] In order to focus and progress research into the problem of PF OA, a one-day meeting (April 2016) was organized in Rotterdam, The Netherlands. The aim of the meeting was to bring together international experts in the field to discuss the current state of knowledge on PF OA. Experts of multiple disciplines (e.g. physiotherapy, rheumatology, orthopaedics, radiology, epidemiology, human movement sciences, general health sciences) were invited based on their scientific publications in the field of PF OA and interest in the subject. Topics that were discussed included the diagnosis, impact, prognosis and treatment of PF OA. Following some context-setting presentations, an interactive discussion was held in order to achieve consensus on the PF OA topics of interest: 1) Diagnosis and definition; 2) Burden; 3) Outcome measures; 4) Prognosis; 5) Risk factors and, 6) Treatment. Consequently, groups of meeting attendees were asked to review the literature on these specific topics and to narratively summarize the current state of knowledge. In addition, each group was tasked with formulating research agenda items relevant to the specific topics of interest. Each consortium member consequently ranked the importance of all items on a 0-10 Numerical Rating Scale (NRS) (10 = extremely important, to 0 = not at all important). We present here a position statement, including the current status of knowledge in the field of PF OA and a research agenda to guide future research on this topic.
Diagnosis and definition of PF OA 2.0.1 PREVALENCE AND INCIDENCE
A recent systematic review has described the prevalence of radiographically confirmed PF OA in different populations [2] . The prevalence was found to be 25% (95%CI 15-37%) in populationbased cohorts and 39% (95%CI 25-54%) in symptom-based cohorts. Further analyses revealed that approximately half of the individuals with radiographic knee OA do have some degree of PF OA. In particular, females (aged years appeared to have a higher prevalence of PF OA (41%) compared to males (aged years (23%) [2] . The incidence of PF OA has been less frequently described in the literature with varying ranges reported: 4.6% in people (mean age 55.9 years, 80% female) with early OA symptoms within 5 years, compared to 28% in a 3-year period in a general older population (mean age 64.8 years, 51% female) [3, 4] . Thus, the prevalence of PF OA appears to be high, with a substantial number of people having isolated PF OA (~40%). While the prevalence of isolated PF OA and combined OA in both the PF joint and TF joint appears to be similar [3, 4] , combined OA seems to be more prevalent than isolated PF OA in people with symptoms of knee pain [5] [6] [7] . The different prevalence rates of PF OA found across studies may be due to the different radiographic criteria applied, but may also reflect the diversity in populations studied [2] .
IMAGING DEFINITION
Radiography has been the most frequently applied imaging technique used to diagnose and stage PF OA, although specific scoring systems for PF OA do not currently exist. The Kellgren and Lawrence [8] (KL) grading system is frequently used to define radiographic PF OA, especially in research settings [4, 9, 10] , and relies on the presence of osteophytes and joint space narrowing. However, one should be aware that this method was originally developed for TF OA and that its validity for PF OA has not been assessed. Hence, it is unknown whether the KL grading system is in fact an appropriate tool to assess PF OA. Nevertheless, it has been shown that the sensitivity for detecting radiographic PF OA features is increased when specific radiographic projections of the PF joint are obtained, particularly skyline views [10, 11] . It is therefore important to include a skyline view X-ray in order to detect osteophytes and joint space narrowing of the PF joint. In a recent systematic review of studies evaluating the prevalence of radiographic PF OA, it was found that most included studies used lateral and/or skyline views to define PF OA [12] . Some studies have used these two views in the supine position with the knee flexed to 45 degrees [10] , while others have used weight bearing radiographs with 30 degrees of knee flexion for the lateral views and non-weight bearing skyline view radiographs with knees in 30 degrees flexion [4] . However, the impact of the knee position on the prevalence of radiographic findings remains unknown.
Magnetic resonance imaging (MRI) is increasingly performed in OA research because of its ability to directly visualize a range of joint tissues involved in PF OA, such as articular cartilage, synovium and fat pads. Several semi-quantitative MRI scoring methods exist, such as the MRI OA Knee Score (MOAKS) [13] , which all include the PF joint as a sub-region. The presence, severity and location of several OA features on MRI have been related to PF OA symptoms [14] . An MRI definition of PF OA has been proposed requiring the presence of a definite osteophyte along the PF joint in combination with partial or full thickness cartilage loss [15] , however the utility of this definition has not yet been explored.
CLINICAL DIAGNOSIS
In clinical practice, a clinical history and physical examination can yield information to identify knees with PF pain [16] . Stefanik et al. [17] found a sensitivity and specificity for the presence of isolated PF OA of 60% and 53%, respectively for the presence of anterior knee pain (pain on or around the patella) [17] . Absence of moderate pain while walking on level ground had the highest sensitivity (93%) but also the lowest specificity (13%). The combination of anterior knee pain and moderate pain with stair climbing had the highest specificity (97%), but low sensitivity (9%).
Features from physical examination may enhance the ability to distinguish PF OA from TF OA. For example, crepitus (defined as hearable grinding noise and/or palpable vibrations in the knee detected by the hand of the investigator rested on the patella of the patient while squatting) was significantly associated with PF OA features seen on MRI, including cartilage lesions, osteophytes and bone marrow lesions, but not with features of TF OA [18] . Therefore the core clinical criteria to define PF OA should at least include the presence of anterior knee pain during weight bearing activities such as stair ambulation. An additional criterion could be the presence of crepitus. Symptoms and impairments associated with PF OA are not the same as those associated with TF OA [19, 20] . Moderate to severe isolated PF OA may be characterized by a history of dramatic swelling, valgus knee deformity, pain on PF joint compression, and reduced quadriceps strength [20] . In the same study, clinical features of TF OA include effusion, bony enlargement, varus deformity, reduced knee flexion range of motion, and mediolateral instability [20] .
Radiographic and MRI features of PF OA appear to have an independent impact on symptoms and disability [20] , and to be more strongly associated with pain and functional limitations than imaging features of TF OA [6, 21, 22] . In people with knee pain, worsening radiographic severity of isolated PF OA is associated with worse scores on the pain, stiffness and function subscales of the Western Ontario and McMaster Universities Arthritis Index (WOMAC [23] ) [1, 4] , crepitus with knee flexion [4] , and stiffness after sitting or resting during the day [1, 4] . While pain descending stairs is the functional task most strongly associated with severity of isolated PF OA, pain experienced when getting in and out of a bath or car, rising from bed, ascending stairs, and rising from sitting are also associated with PF OA [1] . The coexistence of PF OA with medial TF OA appears to result in worse pain ascending and descending stairs, compared to those with isolated medial TF OA [24] .
MRI features of PF OA have been shown to predict worsening of patient-reported pain, symptoms, function and quality of life over two years, in an at-risk population who have undergone anterior cruciate ligament (ACL) reconstruction [25] . Importantly, the presence of PF OA has implications for the health of other knee joint compartments. The PF joint is often the first knee compartment affected by OA, and isolated symptomatic PF OA increases the risk of future TF OA development [3] .
Although no studies have investigated measures of personal burden in people with PF OA, baseline data from clinical trials highlight the personal burden of PF OA when compared to published normative values. Two studies used the Knee injury and Osteoarthritis Outcome Score (KOOS), in 126 people (mean age 55 years) [9] and 92 people (age 55 years) [26] with PF OA. Figure 1 highlights deficits across all KOOS subscales in people with PF OA compared to normative values [27] . However, this is especially evident for the knee-related quality of life subscale, which is markedly lower in people with PF OA.
SOCIETAL BURDEN
PF OA has only recently been recognized as a distinct subgroup of knee OA [19] . It is therefore not surprising that the societal burden of PF OA has not been evaluated (e.g. quality adjusted life years, financial costs). While numerous studies have quantified the burden of general knee OA [28] [29] [30] , it cannot be assumed that these findings apply to predominant or isolated PF OA. Not only are PF OA symptoms and impairments different to TFOA, but PF OA tends to affect younger adults than TFOA [31] . Considering that younger adults typically have greater responsibilities (e.g. occupation, child care), it is plausible that burden of disease measures, such as years lived with disability, would be higher in PF OA than TF OA.
RESEARCH AGENDA
 Quantify the societal burden of PF OA using well-designed studies or existing cohorts  Quantify the personal burden of PF OA by comparing people with PF OA and matched controls on measures of function, health-related quality of life, and work participation  Determine and clarify how impairments associated with PF OA differ from those with TF OA
Outcome measures for PF OA 2.3.1 PATIENT REPORTED OUTCOME MEASURES (PROMS)
The OARSI have recommended a core set of outcome measures for knee OA [32] [33] [34] : pain, physical function and patient global assessment. Similar PROMS have been advised for patellofemoral pain [35] . However, up to now, no specific PROMs have been developed specifically for PF OA. Clinical trials in people with PF OA have used PROMs that are generic (e.g. pain visual analogue scale) or intended for general knee OA (e.g. Knee injury and Osteoarthritis Outcome Score [KOOS] [36] , WOMAC [23] ) [9, 26, 37, 38] . Because PF OA symptoms and impairments are not the same as tibiofemoral OA [19, 20] , PROMs intended for general knee OA may not have adequate content validity for PF OA. Furthermore, the measurement properties of these PROMs have not been evaluated in PF OA, which is problematic because measurement properties are populationspecific [39] . Thus, we cannot make evidence-based recommendations for PROMs for PF OA at this time.
PHYSICAL PERFORMANCE MEASURES
OARSI have recommended a set of physical performance measures for individuals with hip or knee OA [34] . It was emphasized that these tests may be ideal for most OA populations, but may not be challenging enough for early-stage knee OA patients. Additionally, these tests have not specifically been tested in a PF OA population. Few physical performance measures have been examined in PF OA cohorts, despite recommendations to incorporate these into clinical and research assessments [40] . A recent pilot study (n=8) examined the impact of PF OA on the Timed Up and Go Test and 50 foot Fast Paced Walk Test. Only Timed Up and Go performance was significantly different to healthy age-matched controls [41] . This is likely because, unlike the TF joint, the PF joint is not loaded during level walking. While Timed Up and Go has moderate construct validity in a knee OA cohort (including PF OA and/or TF OA) [42, 43] , no other measurement properties have been evaluated. As such, we need to know whether the currently recommended tests are also reliable, valid and sensitive in a PF OA population and whether other or additional physical performance are needed for PF OA patients.
STRUCTURAL OUTCOME MEASURES
Structural changes can be assessed using different imaging modalities. As already discussed above, the presence of osteophytes and joint space narrowing can be assessed on plain radiographs using the KL grade [8] or other more detailed methods [44] [45] [46] [47] [48] , while alignment and joint space width can also be measured [49] . More sensitive MRI-based semi-quantitative scoring systems include WORMS [50] , BLOKS [51] and MOAKS [13] , which assess features such as bone marrow lesions, cartilage defects, infrapatellar fat pad, synovitis and effusion. However, the validity and sensitivity of these methods have only been thoroughly studied for general knee OA, and not specifically for PF OA. Promising quantitative MRI techniques enable assessment of cartilage composition, cartilage morphometry, morphological assessment of various tissues, patellar bone blood perfusion and the degree of bone remodeling [49, [52] [53] [54] [55] . These techniques are still under development, and require further validation, correlation with clinical and semi-quantitative measures, and standardization.
OTHER (E.G. BIOCHEMICAL BIOMARKERS)
Some soluble OA biomarkers have been associated with the prediction of the onset and progression of OA. [56] These can be acquired from biological fluids including serum, synovial fluid and urine, and provide a perspective on the physiologic state of joint tissues. It is important to note that serum and urine markers reflect total body turnover and are not restricted to the joint of interest. To be clinically useful these biomarkers need further qualification studies. 
RESEARCH

Prognosis
Few studies have reported on the natural history of PF OA, and those that have been conducted almost solely focus on structural progression assessed with radiographs or MRI.
Progression to radiographic PF OA in a population of middle-aged people with knee pain for more than 3 months was 31% over 6 years [57] , and 17% over 3-years in people over 50 years with any knee pain in the last year [3] . The latter study also showed a 3-year cumulative progression of 19% of mild PF OA to moderate/severe PF OA; TF OA progression was 25% in the same cohort. Progression of the component radiographic features, joint space narrowing and osteophytes, was observed in a cohort study of people with unilateral meniscectomy [58] and in a prospective cohort study of people with early stage symptomatic knee OA [59] . In the meniscectomy cohort, 30% of people progressed one grade in their radiographic score of the index knee (5% in joint space narrowing; 27% in osteophytes) and 19% progressed one grade in the contralateral knee (7% in joint space narrowing; 15% in osteophytes) in 4 to 10 years. In the early knee OA population, PF progression of joint space narrowing and osteophytes was observed in 9.2% and 15.4% respectively; less frequently than in the TF joint (28.6% and 29.3% respectively) [59] . Thus, it appears that structural progression of PF OA occurs less frequently than TF OA, although limited studies report on the progression of PF OA separately from TF OA and combined knee OA. More importantly, no studies so far have reported on the clinical progression of PF OA.
The longitudinal inter-relationship between PF OA and TF OA has been described in multiple studies. Having TF OA was found to be a risk factor for onset and progression of PF OA in 3 or more years, and having PF OA was a risk factor for developing TF OA, both in knee pain populations using radiographic definitions [3, 4] , and in a female middle-aged population using MRI definitions [60] . A cohort of people with meniscectomy showed that 24% with unilateral TF OA, and 14% with unilateral PF OA, had bilateral radiographic disease 4-10 years later [58] . In the early OA knee cohort, the six-year radiographic progression of joint space narrowing and osteophytes in PF joint and TF joint were not related. However, there was an association between the progression of joint space narrowing and osteophytes of the PF joint and MRI features of medial TF joint [59] . So TF OA and PF OA seem inter-linked with each other, but future research needs to explore the relation between the joints more extensively.
In MRI studies that report the progression of cartilage volume loss in the PF joint, an annual 1.6% loss of cartilage volume was reported in a study population consisting of women (mean age 52 years) without clinical knee OA [61] . In two other studies consisting of patients with knee OA (both mean age 63 years) and radiographic evidence of knee OA (osteophytes and/or joint space narrowing) the annual loss of cartilage volume was 4.5% [62, 63] . Women seem to lose patellar cartilage at a faster rate than men [62, 63] .
RESEARCH AGENDA
 What is the clinical trajectory of people with symptomatic PF OA?  How are PF OA and TF OA inter-linked?
Risk factors for the onset and progression of PF OA
Several factors are hypothesized to alter the mechanics of the patellofemoral joint, leading to increased joint stresses, which can in turn lead to OA. These factors and impairments can be divided into four groups:
ABNORMAL PATELLOFEMORAL JOINT ALIGNMENT AND ABNORMAL TROCHLEAR MORPHOLOGY
One systematic review concluded that strong evidence supports the association between PF OA and both abnormal trochlear morphology and knee alignment (hip-knee-ankle angle and TF angle) in the frontal plane [64] . While longitudinal studies are still absent, there is limited evidence that malalignment in the sagittal plane (patella alta) and axial plane (lateral patellar displacement and tilt) are cross-sectionally associated with PF OA. However, an evidence gap remains regarding optimal measures and thresholds in these factors to optimize the prediction of PF OA. Therefore, future studies should assess both TF alignment (using posteroanterior radiographs [65] ) and PF alignment (using skyline radiograph or MRI [64] ).
KINETIC AND KINEMATIC ABNORMALITIES
Several studies have found that quadriceps muscle size [66] , strength [20] , [67] and force [68] is reduced in people with PF OA compared to people with no PF OA. Additionally, greater quadriceps strength has been found to be a protective factor against pain and cartilage loss over 30-months in the PF joint [69] .
Weakness of muscle groups proximal to the knee (including but not limited to the glutei) have been extensively reported in young individuals with non-arthritic PF pain, which has been suggested to be a precursor of PF OA [70] [71] [72] [73] [74] . Recent data suggest that compared to healthy controls, individuals with PF OA may also demonstrate proximal muscle dysfunction, including lower gluteus minimus and medius peak muscle force [75] and lower hip abductor strength [76] . However, these studies did not find differences between controls and patients in gluteus maximus peak muscle force [75] or hip external rotator strength [76] . Thus, in the absence of longitudinal evidence, the exact causal relationship between hip muscle weakness and PF OA remains unknown.
Altered joint mechanics may be important in disease onset, disease progression and symptom severity. Contradictory evidence suggests that abnormal biomechanics during gait can be observed in individuals with PF OA [68, 75, [77] [78] [79] . Pohl et al. reported that there were no differences in pelvis, hip and knee kinematics between people with PF OA and controls during level walking [76] . Folk et al. assessed stair ascent and descent which is more stressful to the PF joint and is a commonly reported functional problem. [68] They found those with PF OA had lower knee extension moments, quadriceps forces and PF joint reaction forces [68] . The only longitudinal study to date found that subjects who demonstrated higher peak knee flexion moments and flexion moment impulses, had progression of PF cartilage damage within 2 years [79] . Given limitations in skin marker-based technology systems for the PF joint, fluoroscopy or loaded imaging methodologies could be considered.
ACL RUPTURE AND RECONSTRUCTIONS
Previous studies have shown imaging evidence of PF OA following ACL injury and reconstruction [80] [81] [82] [83] [84] [85] [86] [87] , apparently unaffected by reconstruction using hamstring tendon or bonepatellar-bone autograft. The role of reconstruction in the development of PF OA is unknown [88] . It has been hypothesized that the development of PF OA is related to modified biomechanics which results in chondral damage [86, 89] . ACL injury is also associated with worse symptoms and function [87] , as well as deteriorating symptoms [25] of PF OA.
OTHER
Possible risk factors for progressive loss of patellar cartilage were age, BMI and more severe pain scores at baseline. [62, 63] There is also a suggestion that exercise is associated with less patellar cartilage deterioration [12, 61] . Known risk factors for progression of OA (woman, age, BMI) have shown to be risk factors for progression of PF cartilage deterioration. The presence of modifiable risk factors including obesity (using body mass index) and physical activity (using a validated accelerometer) should be assessed when possible in order to gain better insight into the role of these risk factors in the onset and progression of PF OA, since this is largely unknown. 
RESEARCH
NON-PHARMACOLOGICAL NON-SURGICAL INTERVENTIONS
Clinical guidelines emphasize that OA treatments should be individualized to optimize clinical outcome [90] [91, 92] . Although tailored treatment based on compartmental disease patterns seems appropriate, few studies have evaluated exercise and physical interventions specifically for patients with PF OA. Thus, there is limited evidence presently to guide management of PF OA (Table 1 ).
TAPING & BRACING
Patellar taping and bracing aim to reduce patellar malalignment. Two small cross-over studies in patients with PF OA evaluated the specific effects of taping. These studies showed that taping immediately reduces patellar malalignment and can reduce pain by 15%-25% [93, 94] . The only randomized controlled trial (RCT) to evaluate taping in knee OA confirmed patellar taping reduced pain and disability when applied for 3 weeks in 87 patients with mixed compartment OA, most with PF involvement [95] . However, given patients were not selected on the basis of radiographic or symptomatic PF OA, it is possible that taping may be even more effective in patients with predominant PF OA. It is unclear how taping achieves pain relief in PF OA. Research from younger people with PF pain suggests the pain relief may be due to subtle changes in patellar position that increase PF contact area and reduce PF joint stress [96, 97] . However, this mechanism has not been evaluated in a population with PF OA.
Two studies have investigated the same patellar brace in PF OA with mixed results. Hunter et al [98] employed a double-blind RCT to evaluate a realigning PF brace compared to a non-realigning PF brace over 6 weeks in people with symptomatic, predominantly lateral, PF OA. Both braces led to pain reduction but with no difference between braces. Callaghan et al [9] compared the same realigning patellar brace to no brace in people with PF OA over a 6 weeks RCT. The brace used a realigning strap to seat the patella within the trochlea and people were given the option to use the re-aligning strap; 66% chose not to do so. The brace resulted in modest but significant pain relief, as well as the shrinking of PF bone marrow lesions. Since then, data have shown that in persons with PF OA this patellar brace alters patellar position and increases contact area between the patella and femoral trochlea [99] . But it is unclear whether benefits observed with bracing are due to non-specific (placebo) effects, re-alignment and/or compression of the patella.
COMBINED INTERVENTIONS
Two trials evaluated the efficacy of multi-modal physiotherapy programs for PF OA [26, 37] . Quilty et al [37] used a Zelen RCT to test a complex package of interventions including thigh and hip muscle exercises, patellar taping, and advice regarding footwear and weight reduction. Findings showed no benefit compared to standard physiotherapy treatment for pain or function at 10 weeks, although the intervention group reported greater quadriceps strength. Crossley et al. (2015) [26] investigated a similar intervention program, but with more individual targeting of treatment elements and progressions (based on participant response). Compared to physiotherapy education alone, the treatment group reported significantly greater improvements in pain immediately following treatment cessation at 3 months, but benefits were not maintained 6 months later.
Relative to people with TF OA, there is a dearth of research investigating non-pharmacological nonsurgical treatments for PF OA. Limited evidence suggests that either a complex package of physiotherapist-delivered interventions, or patellar taping or bracing in isolation, may immediately reduce pain associated with PF OA, but whether this is more effective than a more general intervention suitable for TF OA is not clear. There is also no evidence that any exercise or physical intervention for PF OA has lasting clinical benefits.
PHARMACOLOGICAL AND SURGICAL INTERVENTIONS
To our knowledge, there is only one surgical clinical trial specifically in a PF OA population, with this study evaluating the effectiveness of patellar resurfacing compared with patellar retention in a PF OA population with KL grade 4 [100] . Despite the different methods of surgery, postoperative radiological assessment outcomes (patellar tilt, mechanical femorotibial angles and congruence angle) between the two groups were almost identical. Thus there is very limited evidence from pharmacological trials (none so far) and surgical trials for the effectiveness of these interventions for PF OA.
RESEARCH AGENDA AIMS
 Determine the optimal and most cost-effective non-pharmacological treatment for people with PF OA via comparative effectiveness trials  Evaluate if the presence of PF OA moderates short-and long term OA treatment outcomes in people with combined compartmental patterns of OA  Determine if people with isolated PF OA require different treatment strategies, including separate muscle strengthening strategies, to those with combined PF and TFOA  Establish whether other biomechanical interventions (e.g. footwear, foot orthoses, tibial realignment braces) are effective for PF OA  Determine if treatments can modify PF joint structure in those with PF OA in order to slow disease progression and improve long-term outcomes  Determine moderators of outcome from non-pharmacological treatment in people with PF OA so that treatment regimens can be better tailored to the individual  Determine if muscle strengthening or exercise can slow down the progression of cartilage loss in PF OA
Future directions
The PF OA expert group observed knowledge gaps in the research field of PF OA and formulated a research agenda, based on the narrative reviews performed by the consortium members. After ranking all formulated items on importance, six of the 28 research agenda items received an average of 7.5 points (the ten highest ranked items are presented in Table 2 ). The most highly ranked items covered the fields of treatment and diagnosis and definition of PF OA. We recommend to develop clear clinical criteria for PF OA and to reach consensus on the definition of PF OA by both radiograph and MRI. Additionally, more understanding is necessary in order to be able to isolate PF symptoms from those arising from the TJ joint. Clearly, more knowledge is needed on the clinical trajectory of people with PF OA and risk factors for symptomatic and/or radiographic progression of PF OA, since longitudinal studies investigating these are scarce. Evidently, more insight is needed in possible effective treatment strategies for PF OA; How can non-pharmacological treatments in people with PFOA be better tailored to the individual and do people with isolated PF OA require different treatment strategies? This implies that there is clearly need to evaluate moderators and effectiveness of treatment outcome in people with PF OA. 
